NCT00896701View on ClinicalTrials.gov

Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

CompletedOBSERVATIONAL
Enrollment

451

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Leukemia
Interventions
OTHER

flow cytometry

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

Trial Locations (2)

28501

Kinston Medical Specialists, Kinston

43210-1240

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00896701 - Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 | Biotech Hunter | Biotech Hunter